From Ticker Sense
Friedman Billings downgraded MEDI this morning from Outperform to Market Perform. Of all the analysts covering the stock, Friedman Billings has had the best performance over the past year according to Bloomberg’s BARR rankings.
From Ticker Sense
Friedman Billings downgraded MEDI this morning from Outperform to Market Perform. Of all the analysts covering the stock, Friedman Billings has had the best performance over the past year according to Bloomberg’s BARR rankings.